LGM
VERA icon

Logos Global Management’s Vera Therapeutics VERA Stock Holding History

Logos Global Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-875,000
Closed -$37M – 56
2024
Q4 		$37M Buy
875,000
+375,000
+75% +$16.6M 4.33% 5
2024
Q3 		$22.1M Sell
500,000
-450,000
-47% -$17.1M 2.38% 18
2024
Q2 		$34.4M Buy
950,000
+375,000
+65% +$14.9M 2.76% 12
2024
Q1 		$24.8M Buy
+575,000
New +$20.5M 2.01% 17
2023
Q1 		– Sell
-285,000
Closed -$5.51M – 48
2022
Q4 		$5.51M Buy
+285,000
New +$5.16M 0.65% 32
2022
Q2 		– Sell
-385,000
Closed -$9.04M – 41
2022
Q1 		$9.04M Buy
385,000
+335,000
+670% +$7.21M 1.17% 23
2021
Q4 		$1.34M Buy
+50,000
New +$1.11M 0.14% 59

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Logos Global Management's VERA Position: Q1 2025 in Review

Logos Global Management sold out of Vera Therapeutics (VERA) in Q1 2025, closing a stake of 875,000 shares — an estimated $37M sold.

Logos Global Management first reported a position in VERA in Q4 2021 and held it in 7 quarters. The position peaked at $37M in Q4 2024. 179 funds tracked by Wall St. Rank hold VERA as of Q1 2025.

  • Logos Global Management reported no remaining Vera Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Logos Global Management sold 875,000 Vera Therapeutics shares in Q1 2025, an estimated $37M.
  • Logos Global Management first reported a position in Vera Therapeutics in Q4 2021 and held it in 7 quarters.
  • Logos Global Management's Vera Therapeutics position peaked at $37M in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2025.

Based on Logos Global Management's 13F filing for Q1 2025, filed 15 May 2025.